Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
25 juil. 2024 07h00 HE
|
Sol-Gel Technologies Ltd.
Sol-Gel Announces the Signing of Six Exclusive License Agreements to Commercialize TWYNEO® and EPSOLAY® in Europe and South Africa
India Skin Boosters Market Size, Share & Trends Analysis Report 2024-2030 Featuring Sinclair Pharma, Medytox, AbbVie, Merz Pharma, Galderma, Teoxane, IBSA farmaceutici, Allergan, PharmaResearch
19 juil. 2024 04h54 HE
|
Research and Markets
Dublin, July 19, 2024 (GLOBE NEWSWIRE) -- The "India Skin Boosters Market Size, Share & Trends Analysis Report By Type (Mesotherapy, Micro-needle), By Gender (Female, Male), By End-use...
萬聯行在香港獲得Targretin®️(Bexarotene)用於皮膚T細胞淋巴瘤的上市批准
16 juil. 2024 02h54 HE
|
MAIN LIFE CORPORATION LIMITED
香港和澳門的獲批為Targretin®️首次在中國區域內上市Bexarotene為國際臨床慣例用於治療復發性皮膚T細胞淋巴瘤(CTCL)的標準藥物 香港, July 16, 2024 (GLOBE NEWSWIRE) --...
万联行获得Targretin®(Bexarotene 贝沙罗汀)在香港用于皮肤T细胞淋巴瘤的市场批准
16 juil. 2024 02h54 HE
|
MAIN LIFE CORPORATION LIMITED
香港和澳门的批准标志着Targretin®首次在中国上市贝沙罗汀代表国际临床实践中对复发性皮肤T细胞淋巴瘤(CTCL)的标准治疗 香港, July 16, 2024 (GLOBE NEWSWIRE) -- 万联行有限公司(“Main Life”)今天宣布Targretin®(贝沙罗汀)胶囊在香港获得上市许可,用于治疗至少一次系统治疗无效的皮肤T细胞淋巴瘤 (Cutaneous T-cell...
Main Life received Targretin® (Bexarotene) Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma
16 juil. 2024 02h54 HE
|
MAIN LIFE CORPORATION LIMITED
Targretin® (Bexarotene) received Marketing Authorisation in Hong Kong for Cutaneous T-Cell Lymphoma.
Global Dermal Fillers Market Insights, 2024-2029 - AbbVie, Galderma, Merz Pharma, Sinclair, and Teoxane Dominate the $9.98 Billion Projected Market
12 juil. 2024 11h07 HE
|
Research and Markets
Dublin, July 12, 2024 (GLOBE NEWSWIRE) -- The "Global Dermal Fillers Market - Focused Insights 2024-2029" report has been added to ResearchAndMarkets.com's offering.The global dermal fillers market...
Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors
11 juil. 2024 16h05 HE
|
Journey Medical Corporation
SCOTTSDALE, Ariz., July 11, 2024 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and...
Dermatology Group of Arkansas Member Earns Nursing Degree
27 juin 2024 10h57 HE
|
Dermatology Group of Arkansas
LITTLE ROCK, Ark., June 27, 2024 (GLOBE NEWSWIRE) -- As a longtime provider of surgical, cosmetic, and medical dermatology procedures in the Little Rock area, Dermatology Group of Arkansas is well...
Quoin Pharmaceuticals Announces International Expansion of Ongoing Clinical Trials for Netherton Syndrome
27 juin 2024 08h00 HE
|
Quoin Pharmaceuticals, Inc.
Clinical site to be Opened in Saudi Arabia Site Currently Treating Netherton Patients Who Are Eligible for Recruitment into Quoin Studies Experienced Local Clinical Research Organization Has...
U.S. Tattoo Studios & Tattoo Removal Services Market Analysis 2024: Historical Demand 2007-2023, Consumer Demographics 2024-2030, Competitor Profiles by State
27 juin 2024 04h28 HE
|
Research and Markets
Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "U.S. Tattoo Studios & Tattoo Removal Services: A Market Analysis" report from Marketdata LLC has been added to ResearchAndMarkets.com's offering. ...